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Mechanisms of lysine-induced acute renal failure in rats. We have
previously found that lysine produces acute renal failure in rats. To
define the acute effects of lysine, rats given lysine at 8.9 mg/kg/mm, i.v.
for 4.5 hr were compared with control rats receiving equiosmolar
dextrose. Systemic blood pressure was stable in both groups. Mean
intratubular pressure, inulin clearance (C1), and renal blood flow were
determined at 45-mm intervals. Intratubular pressures measured with a
servonulling micropressure device were elevated by 90 mm in lysine-
treated animals, with tubular heterogeneity, while pressures in dextrose-
treated rats were normal and homogeneous. By 135 mm C1,, in lysine-
treated rats was 45% of C1,, in dextrose rats. Urine output fell in
lysine-treated rats. Renal blood flow determined by flow probe re-
mained normal in lysine-treated rats through 135 mm and did not
decline significantly until 180 mm. Significant dilatation of surface
tubules was documented by intravital microscopy beginning at 90 mm in
lysine-treated rats. The sequence of elevated intratubular pressure and
tubular dilatation, followed by decreased C1,,, and then by decreased
renal blood flow suggests that lysine produces acute renal failure
primarily through tubular obstruction. The tubular obstruction is fol-
lowed later by an increase in renal vascular resistance.
Mécanismes de l'insuffisance rénale aiguë induite par Ia lysine chez des
rats. Nous préalablement trouvhmes que la lysine entraine une insuf-
fisance rénale aigue chez les rats. Afin de ddfinir les effets aigus de Ia
lysine, des rats ayant recu de la lysine a 8,9 mg/kg/mm iv. pendant 4.5
hr ont été compares a des rats contrOles recevant du glucose
équimolaire. La pression artérielle systémique était stable dans les deux
groupes. La pression intratubulaire moyenne, Ia clearance de l'inuline
(C1,,) et le flux sanguin renal ont été déterminés a des intervalles de 45
mm. Les pressions intratubulaires mesurées avec un appareil a
micropression asservi étaient élevées des 90 mm chez les animaux
traités avec Ia lysine, avec une hétérogénéite tubulaire, tandis que les
pressions des rats traités au glucose étaient normales et homogènes. Au
bout de 135 mi Ci,, des rats traités par Ia lysine était de 45% de C1,, des
rats glucose. Le debit urinaire a chute chez les rats traités par la lysine.
Le debit sanguin renal déterminé par une sonde de flux est resté normal
chez les rats traités par Ia lysine pendant 135 mm, et n'a pas décliné
significativement jusqu'à 180 mm. Une dilatation significative des
tubules superficiels a été documentée par microscopie intravitale,
comencant a 90 mm chez les rats traités par la lysine. La sequence de
pression intratubulaire élevée et de dilatation tubulaire, suivie par une
C,,, diminuée, puis par une diminution du flux sanguin renal suggCre que
Ia lysine entraine une insuffisance rénale aigue essentiellement par
obstruction tubulaire. L'obstruction tubulaire est suivie plus tard d'une
élévation de Ia résistance vasculaire rénale.
Amino acid therapy has been advocated for patients with
acute renal failure [1, 2], and there is experimental evidence in
rats that amino acid administration speeds tubular regeneration
following acute tubular necrosis [3, 4]. However, it now ap-
pears that some amino acids or amino acid mixtures can depress
renal function, especially if given in combination with other
nephrotoxins [5, 6] or in the setting of renal ischemia [7]. For
example, we have previously reported that a 4-hr infusion of the
dibasic amino acid lysine in rats reduced glomerular filtration
rate (GFR) by approximately 50% [6]. An acute decrease in
GFR following large doses of acidic, basic, and neutral amino
acids has also been reported [8]. The mechanism of this renal
dysfunction, however, remains unclear.
To further define the nephrotoxic properties of amino acid
solutions, clearance and micropuncture studies were performed
in conjunction with morphologic studies during the evolution of
lysine-induced acute renal failure. The renal insufficiency de-
veloped gradually over several hours, making it possible to
perform sequential measurements of inulin clearance,
intratubular pressures and renal blood flow, and sequential
intravital microscopy to further delineate the pathogenesis of
lysine-induced acute renal failure. The data from the
micropuncture studies in the present study indicate that lysine-
induced acute renal failure is characterized by an initial tubular
obstruction, followed by a significant decrease in GFR and
urine output, with the later development of increased renal
vascular resistance and reduced renal blood flow.
Methods
All studies were performed in nonfasted male Munich-Wistar
rats weighing 210 to 290 g and obtained from Simonsen Labs,
Gilroy, California, USA.
Inulin clearance, micropuncture, and renal blood flow stud-
ies. Following induction of pentobarbital anesthesia, rats were
placed on a temperature-regulated table which maintained body
temperature at 36 to 38°C. A tracheostomy was performed and
the right external jugular vein was cannulated with PE 50
through which saline (0.9% NaCl) was infused at 3.3 cc/hr. The
right femoral artery was canulated with PE 50 for continuous
arterial blood pressure determinations. Abdominal and left
subcostal incisions were made to expose the left kidney which
was stabilized using a diaphragm retractor and body wall clamp.
The kidney was packed in cotton soaked in saline warmed to
37°C, with care to avoid manipulation of the adrenal gland or
traction on the renal pedicle. Ureters were cannulated bilater-
ally. Animals received approximately 3 to 4 cc of saline during
preparative surgery.
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Table 1. Results of micropuncture studies during lysine infusion
45 mm 90 mm 135 mm 180 mm 225 mm 270 mm
BP, mm Hg DEX
LYS
128 5
127 4
129 5
123 4
137 4
124 4 131 6129 3 132 4128 4 127 4127 3
Hct, % DEX
LYS
51 1
52 1
50 1
51 1
49 1
50 1
49 1
50 1
49 1
50 1
51 1
53 I
Urine flow, .d/min DEX
LYS
5.7 2.4
11.8 1.8
4.7 1.4
7.9 1.7
6.9 2.3
3.5 1.0
9.2 3.3
2.9 0.6"
13.9 4.0
3.8 09b
13.0 3.3
3•7 0.7"
ITP, mm Hg DEX
LYS
11.3 0.7
10.7 1.3
12.1 0.7
18.8 20b
12.2 0.6
24.7 4.1"
13.2 1.1
26.5 4.1"
13.3 1.1
31.5 3,3a
14.4 1.3
28.1 42b
C1,,, mi/mm DEX
LYS
0.87 0.07
0.90 0.08
0.82 0.15
0.67 0.12
0.91 0.12
0.33 0.11"
0.91 0.12
0.18 0.04
1.10 0.15
0.23 0.07k
1.01 0.19
0.16 0.03k
RBF, mi/mine DEX
LYS
6.58 0.71
6.43 0.52
6.66 0.50
6.49 0.45
6.90 0.58
6.36 0.45
7.27 0.65
5.32 0.50"
7.31 0.71
4.71 0.26"
7.36 0.83
3.92 043b
RVR, dynsec/cm' DEX
LYS
16.9 1.8
16.9 2.0
15.1 1.8
15.7 2.0
16.6 1.9
15.5 1.8
14.7 2.5
21.4 2.1
14.3 1.5
21.9 19b
14.0 1.8
29.3 45b
Abbreviations: BP, blood pressure; Hct, hematocrit; ITP, intratubular pressure; C1,,, clearance of inulin; RBF, renal blood flow; RVR, renal
vascular resistance; DEX, dextrose; LYS, lysine.
aP < 0.001 vs. dextrose controls by analysis of variance.
b P < 0.05 vs. dextrose controls by analysis of variance.
If the later LYS values are compared with 45-mm LYS values, significant differences do not appear until 225 mm for RBF and 270 mm for RVR.
For other parameters, when the LYS and DEX groups are different, the LYS group is also different from its own 45-mm value.
The animals were divided into two groups: Control animals
were infused with a dextrose solution (220 m, pH 9.3, 238
mOsm) containing 2% inulin at 4.3 cc/hr. Lysine-treated ani-
mals received a solution of lysine-free base (220 m, pH 9.3,
238 mOsm, total 4.40 mmoles) containing 2% inulin infused at a
rate of 4.3 cc/hr (61 tmoles/kgImin). At 45-mm intervals (100
mg increments of lysine) a 10-mm urine collection was per-
formed; blood samples were collected in all rats for inulin
clearance determinations.
In six lysine-treated rats and six dextrose-treated rats, five to
nine random proximal intratubular pressures were determined
at the time of each clearance period using sharpened glass
micropipettes (4 to 6 s O.D.) filled with 2 M NaCI and
connected to a servonulling pressure device (Eutechtic Elec-
tronics, Raleigh, North Carolina, USA). When dilated tubules
were present, punctures were made in tubules that did not
appear dilated as well as in dilated tubules in proportion to their
relative numbers on the cortical surface in view. Renal blood
flow was monitored constantly in ten lysine rats and five
dextrose rats using a noncanulating electromagnetic flow trans-
ducer (2 mm, internal circumference) connected to a square-
wave flow meter (Carolina Medical Electronics, King, North
Carolina, USA). Calibration was confirmed using a segment of
femoral artery according to a technique described by
Arendshorst, Finn, and Gottschalk [9]. The servonulling ap-
paratus, flow meter, and systemic blood pressure transducer
were attached to a polygraph recorder (Grass 78D, Grass
Instrument Co., Quincy, Massachusetts, USA) for continuous
monitoring. The left kidney was harvested from each animal
and prepared for microscopy using standard techniques.
Intravital microscopy. In six other rats, following surgical
preparation, the kidney surface was bathed with warm saline
and covered with a layer of flexible transparent cellophane.
Following stabilization, lysine (N = 3) or dextrose (N = 3)
solutions were then infused as described for micropuncture
studies. At 45-mm intervals, sequential photographs of three
adjacent fields on the kidney surface were taken, using an
incident light microscope (Leitz Ultropak, Ernst Leitz Wetzlar,
Germany) and camera with a 22 x microscope objective and 3M
1000 ASA color transparency film. Fields were selected for a
uniform plane of focus and generally contained a reference
characteristic such as a prominent vessel. When possible, a
superficial glomerulus was included in at least one photographic
field in each animal. Three to six photographs were taken of
each field at each time point, and the photograph best focused
was used for subsequent analysis.
Color slides of each field at each time point were projected,
and all topographical details traced on white tracing paper with
special attention to the tubular lumen and brush border. One to
two proximal tubular luminal diameters were measured at
random orientation in each proximal tubular profile in each
field; the number of measurements in each field at each time
point varied from 14 to 20. When possible, measurements were
generally made adjacent to obvious tissue landmarks so that
identical measurement points could be used in sequential pho-
tographs over the 4-hr observation period. Results were ex-
pressed as luminal diameters (in microns) and absolute changes
in luminal diameter of each tubule from the 45-mm value.
Analytical and statistical techniques. Inulin concentrations
were measured by a standard acid anthrone chemical assay.
Statistical comparisons were performed using the analysis of
variance and Student t test [101. Results are reported as mean
SE. A P value less than 0.05 was considered statistically
significant.
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Fig. 1. Intratubular pressure, inulin clearance, and renal blood flow (mean 5EM) in Iysine and dextrose-treated animals. Significant alterations
are seen in these parameters beginning at 90, 135, and 180 mm, respectively. Symbols are: —•, dextrose; 0—0, lysine; * P < 0.05 compared
to dextrose values.
Results
Inulin clearance, micropuncture, and renal blood flow stud-
ies in rats treated with lysine. At the time of the first clearance
period, 45 mm after the lysine or dextrose infusions were
begun, mean values for arterial blood pressure, hematocrit,
urine flow rates, proximal intratubular hydrostatic pressure,
inulin clearance, and renal blood flow were not different in
dextrose control and lysine experimental groups (see Table 1
and Fig. 1). No significant changes in arterial blood pressure
and hematocrit were observed in either group throughout the
studies. At 45 mm, proximal intratubular pressure averaged
11.3 0.7 mm Hg in dextrose control animals and 10.7 1.3
mm Hg in lysine-treated animals. At 90 mm, however, lysine-
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Fig. 2. Distribution of intratubular pressures at various times after beginning lysine or dextrose infusions. Symbols are: A---A, dextrose; I—s,
lysmne.
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Table 2. Tubular diameter and changes in tubular diameter at 45-mm intervals during infusion of dextrose or lysine
Minutes of infusion
45 90 135 180 225 270
Tubular diameter,
microns DEX (N = 3)
LYS (N = 3)
LYS vs. DEXC
15.9 0.8
17.1 0.8
P> 0.3
16.1 0.7
21.3 1.2
P < 0.02
16.5 1.0
21.6 1.1
P < 0.05
17.0 1.0
22.1 1.7
P < 0.06
16.4 1.1
21.9 1.2
P < 0.05
18.5"
20.4 0.6
MS
Change in diameter,
microns DEX (N = 3)
LYS (N = 3)
LYS vs. DEX0
+0.1 0.1
+4.2 0.7
P < 0.01
+0.7 0.3
+4.9 0.6
P < 0.01
+0.8 0.4
+4.8 0.8
P < 0.02
+0.4 0.1
+4.4 0.6
P < 0.01
+ 1.5"
+2.8 1.2
NS
° The change in diameter was compared to the 45-mm measurement.
b N = 2.
C Student t test values were confirmed by analysis of variance.
treated animals had a significant elevation in mean proximal
intratubular pressure (18.8 2.0 mm Hg) compared to the
45-mm value in these animals (P < 0.01) and to values for
dextrose-infused controls at 90 mm (12.1 0,7 mm Hg, P <
0.01). There was tubular heterogeneity in lysine-treated animals
with some tubules having normal pressure and others elevated
pressures (see Fig. 2). Urine output was well maintained at this
time. By the third clearance period (135 mm), while all param-
eters remained normal in control animals, intratubular pressure
continued to rise (to 24.7 mm Hg, P = 0.01), inulin clearance
fell significantly (P = 0.002) to 36% of values in control
animals, and urine output tended to decrease in lysine-treated
animals. Renal blood flow in lysine-treated rats was unchanged
until the fourth clearance period, when it began to fall. In
contrast, renal blood flow in dextrose-treated animals tended to
rise, perhaps due to volume expansion. Renal blood flow and
inulin clearance remained significantly decreased and
intratubular pressures remained elevated in lysine-treated ani-
mals for the remainder of the 4.5-hr infusion period (see Fig. I).
By paraffin section light microscopy, tubular morphology was
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normal in animals infused with dextrose, with only occasional
apical blebs, and very focal accumulations of intratubular
debris. In contrast, as in previous studies [61 lysine infusion
produced tubular cell swelling and vacuolization, especially at
the cortico-medullary junction, with proximal tubular dilata-
tion, loss of brush border, and accumulation of intratubular
debris in the pars recta.
Intravital microscopy. At 45 mm, tubular-luminal diameters
averaged 15.9 s in dextrose-infused and 17.1 s in lysine-infused
animals, but they were not significantly different. By 90 mm,
tubular dilatation was evident in all lysine animals, with an
average increase of 4.2 t (see Table 2 and Fig. 3). By 135 mm,
there was a striking and uniform increase in tubular diameter,
which persisted through 225 mm. By 270 mm, however, there
was heterogeneity, similar to the pattern seen with intratubular
pressures (see Fig. 2), with some tubules remaining dilated and
others decreasing in diameter. The brightly refractile tubular
brush border became somewhat less apparent as infusion of
lysine progressed, but this was quite variable from field to field
among animals and among fields from the same animal, and may
not have reflected true brushborder loss. By paraffin section
light microscopy, brushborder loss was seen at the cortico-
medullary junction, but not in the superficial cortex (see above).
Even in the most optimal intravital microscopic pictures, the
glomerular images were indistinct and individual glomerular
capillaries could not be seen. Therefore, although no changes in
glomerular diameter were observed, this does not exclude a
change in glomerular capillary caliber.
Discussion
These studies extend the observation that high doses of the
dibasic cationic amino acid lysine in the rat produce a rapid and
sustained decrease in renal function [61. Tubular obstruction
appears to be the primary event in the pathogenesis of this type
of acute renal failure, with a later decrease in renal blood flow.
Lysine is the only essential amino acid which has been shown to
depress renal function.
The micropuncture studies performed during lysine infusion
provide considerable insight into the mechanism of the renal
dysfunction produced by the amino acid. The early elevation in
intratubular pressure and the proximal tubular dilatation seen at
90 mm by intravital microscopy are highly significant and
consistent with tubular obstruction. It is important to note that
at this time whole kidney inulin clearance is not significantly
decreased and renal vascular resistance and renal blood flow
are unchanged. As the infusion continues, mean intratubular
pressures and tubular diameters continue to increase, urine flow
rates decrease in most animals, and inulin clearance falls to
approximately one third of control levels. This condition per-
sists to the end of the infusion period, and in addition, renal
blood flow eventually begins to fall and renal vascular resist-
ance increases.
The kinetics of the functional changes in this animal model
are unusual and make lysine-induced acute renal failure par-
ticularly suitable for physiologic study. While in other models
renal failure develops either very rapidly, as in ischemia, or
quite gradually, as in ureteral obstruction or following admin-
istration of nephrotoxins such as aminoglycosides, lysine-
induced acute renal failure develops over a period of a few
hours, allowing continuous monitoring of functional parameters
as renal dysfunction develops. At early time periods in the
lysine model the micropuncture data and the results of intravital
microscopy are consistent with a somewhat heterogeneous
population of proximal tubules, with some obstructed and some
not. Subsequently, intratubular pressures become more uni-
formly elevated, consistent with widespread tubular obstruc-
tion. At 270 mm, heterogeneity reappears perhaps as a conse-
quence of decreased renal blood flow or decompression of some
tubules.
It is likely that the apparent heterogeneity of tubular pres-
sures and diameters is real and not just the consequence of
making observations proximal to and distal to points of obstruc-
tion. There is no morphologic evidence of obstructing material
in the superficial proximal convoluted tubules accessible to
micropuncture. Tubular debris and cell swelling are seen in the
medullary straight segments of the proximal tubule at 4 hr, and
hyaline casts are seen in the thin limbs of the loops of Henle and
more distal segments at 20 and 48 hr [61 (Racusen, Whelton, and
Solez, unpublished).
The impairment of renal function seen with high dose lysine
infusion is associated with morphologic evidence of tubular
dilatation. Intravital microscopy enabled quantitation of dilita-
tion of surface proximal tubules. The changes in luminal diam-
eter detected by our morphometric methods reflect significant
tubular volume changes. If a segment of tubule is considered a
perfect cylinder, with the volume calculated by the formula ITr2
x h where r is tubular radius and h is tubular length, at a
theoretical length of 1 , a change in diameter from 16 to 20
would produce an increase in tubular volume from 201 to 314
, representing a greater than 50% increase in volume. This
tubular expansion and the elevated intratubular pressures
strongly suggest tubular obstruction.
The initial cause of this functional tubular obstruction is
somewhat difficult to pinpoint, but it is probably related to
plugging the tubule by sloughed brush border and tubular cell
debris, and by loosely aggregated cast material incorporating
filtered protein [111 combined with tubular cell vacuolization
and swelling, which is most striking in the outer stripe of the
outer medulla, well beyond the proximal tubular segments
accessible to micropuncture. A focal obstruction at any point in
the nephron would potentially be sufficient to obstruct free flow
of tubular fluid [121 resulting in obstruction in the absence of
extensive tubular damage or cast formation. The histologic
alterations seen in these studies at 4.5 hr are sufficient to produce
obstruction. At later time periods large numbers of typical
hyaline casts are seen, especially in the thin limbs of the loop of
Henle. These probably form from propogation and condensa-
tion of the loosely aggregated luminal material seen at the end of
the 4.5 hr infusion period. Interestingly, although Tamm-
Horsfall protein is thought to be produced only by cells of the
ascending thick limb [131, these more proximal casts contain
Tamm-Horsfall protein (Racusen, Whelton, and Solez, un-
published) suggesting either that Tamm-Horsfall protein is
produced proximal to the thick ascending limbs, or that these
casts form at least in part by retrograde propagation of casts
which form initially in more distal regions.
The decrease in renal blood flow which is observed late in the
infusion period is probably a consequence of tubular obstruc-
tion. Obstruction may lead to decreased renal blood flow
through compression of peritubular capillaries by distended
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tubules and increased tissue pressure [14, 15] or through
delayed afferent arteriolar constriction due perhaps to a feed-
back mechanism [16—18]. Tubular obstruction with reflex arteri-
olar vasoconstriction has been postulated to contribute to the
renal dysfunction seen in postischemic [19—21] and gentamicin-
induced acute renal failure [22].
Since changes in renal blood flow are a relatively late
phenomenon in lysine-induced acute renal failure, the tubular
degeneration effects and resulting obstruction are most likely
due to a direct toxic effect of the amino acid. Lysine blocks
tubular protein reabsorption [23, 24] and has been used in
diuresing human volunteers in an attempt to totally suppress
albumin reabsorption and thereby determine GFR for albumin
[24]. It seems possible that the elevated protein concentration in
tubular fluid in a lysine-treated animal might increase the
propensity for obstructive cast formation [13]. Possible meta-
bolic effects of producing significant elevations in plasma and
presumably tissue lysine concentrations might be involved in
the pathogenesis of lysine-induced renal dysfunction and re-
quire further investigation.
Although urine concentrations of lysine were not determined,
it is likely that the dose of lysine administered exceeded the Km
for tubular reabsorption [25], especially if the more proximal
tubular segments are damaged by the amino acid. Lysine,
therefore, would be reaching the pars recta and more distal
portions of the nephron at relatively high concentrations, and it
is these segments, especially as they pass through the outer
stripe of the outer medulla, which show evidence of histologic
damage following infusion of the amino acid.
Of the amino acids present in hyperalimentation solutions,
lysine is the only one which has been shown to cause persistent
acute renal failure. It is possible that lysine is the component of
hyperalimentation solutions responsible for their adverse ef-
fects in experimental animals [5, 7] and that similar effects
occur in humans. However, although doses of lysine compa-
rable to those given in the present study have been administered
to human volunteers [24], the amounts of lysine received by a
patient on standard essential amino acid therapy would be at
least 30-fold less. Further clinical studies are necessary to
establish whether hyperalimentation solutions do increase the
risk of acute renal failure in humans, and if so, whether lysine
is responsible for this effect.
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